(window.webpackJsonp=window.webpackJsonp||[]).push([[8,7],{340:function(t,o,e){var content=e(347);content.__esModule&&(content=content.default),"string"==typeof content&&(content=[[t.i,content,""]]),content.locals&&(t.exports=content.locals);(0,e(28).default)("fc6c70cc",content,!0,{sourceMap:!1})},346:function(t,o,e){"use strict";e(340)},347:function(t,o,e){var n=e(27),r=e(32),f=e(33),l=e(34),c=e(35),d=e(36),m=e(37),v=e(38),h=e(39),x=e(40),y=e(41),w=e(42),_=e(43),A=e(44),N=e(45),k=e(46),T=e(47),B=e(48),I=e(49),M=e(50),C=e(51),D=e(52),z=n(!1),O=r(f),R=r(l),E=r(c),S=r(d),j=r(m,{hash:"#AvenirNextRegular"}),P=r(v),F=r(h),J=r(x),L=r(y),V=r(w,{hash:"#AvenirNextMedium"}),Y=r(_),G=r(A),H=r(N),K=r(k),Q=r(T,{hash:"#AvenirNextBold"}),U=r(B),W=r(I),X=r(M),Z=r(C),$=r(D,{hash:"#AvenirNextItalic"});z.push([t.i,'@font-face{font-family:"AvenirNextRegular";font-style:normal;font-weight:400;font-display:swap;src:url('+O+");src:url("+O+') format("embedded-opentype"),url('+R+') format("woff2"),url('+E+') format("woff"),url('+S+') format("truetype"),url('+j+') format("svg")}@font-face{font-family:"AvenirNextMedium";font-style:normal;font-display:swap;src:url('+P+");src:url("+P+') format("embedded-opentype"),url('+F+') format("woff2"),url('+J+') format("woff"),url('+L+') format("truetype"),url('+V+') format("svg")}@font-face{font-family:"AvenirNextBold";font-display:swap;src:url('+Y+");src:url("+Y+') format("embedded-opentype"),url('+G+') format("woff2"),url('+H+') format("woff"),url('+K+') format("truetype"),url('+Q+') format("svg")}@font-face{font-family:"AvenirNextItalic";font-display:swap;src:url('+U+");src:url("+U+') format("embedded-opentype"),url('+W+') format("woff2"),url('+X+') format("woff"),url('+Z+') format("truetype"),url('+$+') format("svg")}.text-bold[data-v-85b1dfba]{font-family:"AvenirNextBold",Arial,sans-serif}.content ul[data-v-85b1dfba]{list-style:disc;margin:16px 0;padding-left:20px}.btn[data-v-85b1dfba]{background-color:transparent;background-image:none;border-radius:7px;border:1px solid #003e51;color:#003e51;cursor:pointer;font-family:"AvenirNextBold",Arial,sans-serif;font-size:14px;min-height:51px;min-width:164px;padding:6px 12px}.btn[data-v-85b1dfba]:hover{background-color:#003e51;color:#fff}.btn[data-v-85b1dfba]:focus{box-shadow:0 0 0 2px #45b979}.btn.btn-green-light[data-v-85b1dfba]{background-color:#45b979;border-color:#45b979;color:#fff}.btn.btn-green-light[data-v-85b1dfba]:hover{background-color:#fff;color:#45b979}.btn.btn-disabled[data-v-85b1dfba]{background-color:#45b979;border-color:#45b979;color:#fff;cursor:default;opacity:.8}.btn.btn-disabled[data-v-85b1dfba]:hover{background-color:#fff;color:#45b979}.bottom-notification[data-v-85b1dfba]{color:#4f5f6e;font-family:Arial,sans-serif}.bottom-notification ul[data-v-85b1dfba]{margin:0 0 20px}.bottom-notification ul li[data-v-85b1dfba]{margin-bottom:4px}.bottom-notification p[data-v-85b1dfba]{color:#003e51}.bottom-notification a[data-v-85b1dfba]{color:#45b979;font-size:14px}.notification-title[data-v-85b1dfba]{color:#003e51;line-height:18px;margin-bottom:4px;text-transform:uppercase}',""]),t.exports=z},348:function(t,o,e){var content=e(360);content.__esModule&&(content=content.default),"string"==typeof content&&(content=[[t.i,content,""]]),content.locals&&(t.exports=content.locals);(0,e(28).default)("59c9c8d5",content,!0,{sourceMap:!1})},349:function(t,o,e){"use strict";e.r(o);var n={},r=(e(346),e(10)),component=Object(r.a)(n,(function(){this._self._c;return this._m(0)}),[function(){var t=this,o=t._self._c;return o("div",{staticClass:"bottom-notification content"},[o("h3",{staticClass:"notification-title"},[t._v("\n    INDICATION\n  ")]),t._v(" "),o("ul",[o("li",[t._v("\n      Trumenba is a vaccine indicated for individuals 10 through 25 years of age for active immunization to prevent invasive disease caused by Neisseria meningitidis group B\n    ")])]),t._v(" "),o("h3",{staticClass:"notification-title"},[t._v("\n    IMPORTANT SAFETY INFORMATION\n  ")]),t._v(" "),o("ul",[o("li",[t._v("\n      Trumenba should not be given to anyone with a history of a severe allergic reaction to any component of Trumenba\n    ")]),t._v(" "),o("li",[t._v("\n      Some individuals with weakened immune systems may have a reduced immune response\n    ")]),t._v(" "),o("li",[t._v("\n      Persons with certain complement deficiencies and persons receiving treatments such as SolirisÂ® (eculizumab), are at increased risk for invasive disease caused by Neisseria meningitidis group B even with receipt of vaccination with Trumenba\n    ")]),t._v(" "),o("li",[t._v("\n      Vaccination with Trumenba may not protect all vaccine recipients against N meningitidis group B infections\n    ")]),t._v(" "),o("li",[t._v("\n      Fainting can occur in association with administration of injectable vaccines, including Trumenba\n    ")]),t._v(" "),o("li",[t._v("\n      The most common adverse reactions in adolescents and young adults were pain at injection site, fatigue, headache, and muscle pain\n    ")]),t._v(" "),o("li",[t._v("\n      Data are not available on the safety and effectiveness of using Trumenba and other meningococcal group B vaccines interchangeably to complete the vaccination series\n    ")]),t._v(" "),o("li",[t._v("\n      Tell your health care provider if you are pregnant, or plan to become pregnant\n    ")]),t._v(" "),o("li",[t._v("\n      Ask your health care provider about the risks and benefits of Trumenba. Only a health care provider can decide if Trumenba is right for you or your child\n    ")])]),t._v(" "),o("p",{staticClass:"text-bold"},[t._v("\n    Please see "),o("a",{attrs:{href:"https://labeling.pfizer.com/ShowLabeling.aspx?id=1796",target:"_blank"}},[t._v("full Prescribing Information")])])])}],!1,null,"85b1dfba",null);o.default=component.exports},359:function(t,o,e){"use strict";e(348)},360:function(t,o,e){var n=e(27),r=e(32),f=e(33),l=e(34),c=e(35),d=e(36),m=e(37),v=e(38),h=e(39),x=e(40),y=e(41),w=e(42),_=e(43),A=e(44),N=e(45),k=e(46),T=e(47),B=e(48),I=e(49),M=e(50),C=e(51),D=e(52),z=n(!1),O=r(f),R=r(l),E=r(c),S=r(d),j=r(m,{hash:"#AvenirNextRegular"}),P=r(v),F=r(h),J=r(x),L=r(y),V=r(w,{hash:"#AvenirNextMedium"}),Y=r(_),G=r(A),H=r(N),K=r(k),Q=r(T,{hash:"#AvenirNextBold"}),U=r(B),W=r(I),X=r(M),Z=r(C),$=r(D,{hash:"#AvenirNextItalic"});z.push([t.i,'@font-face{font-family:"AvenirNextRegular";font-style:normal;font-weight:400;font-display:swap;src:url('+O+");src:url("+O+') format("embedded-opentype"),url('+R+') format("woff2"),url('+E+') format("woff"),url('+S+') format("truetype"),url('+j+') format("svg")}@font-face{font-family:"AvenirNextMedium";font-style:normal;font-display:swap;src:url('+P+");src:url("+P+') format("embedded-opentype"),url('+F+') format("woff2"),url('+J+') format("woff"),url('+L+') format("truetype"),url('+V+') format("svg")}@font-face{font-family:"AvenirNextBold";font-display:swap;src:url('+Y+");src:url("+Y+') format("embedded-opentype"),url('+G+') format("woff2"),url('+H+') format("woff"),url('+K+') format("truetype"),url('+Q+') format("svg")}@font-face{font-family:"AvenirNextItalic";font-display:swap;src:url('+U+");src:url("+U+') format("embedded-opentype"),url('+W+') format("woff2"),url('+X+') format("woff"),url('+Z+') format("truetype"),url('+$+') format("svg")}.text-bold[data-v-315afb57]{font-family:"AvenirNextBold",Arial,sans-serif}.content ul[data-v-315afb57]{list-style:disc;margin:16px 0;padding-left:20px}.btn[data-v-315afb57]{background-color:transparent;background-image:none;border-radius:7px;border:1px solid #003e51;color:#003e51;cursor:pointer;font-family:"AvenirNextBold",Arial,sans-serif;font-size:14px;min-height:51px;min-width:164px;padding:6px 12px}.btn[data-v-315afb57]:hover{background-color:#003e51;color:#fff}.btn[data-v-315afb57]:focus{box-shadow:0 0 0 2px #45b979}.btn.btn-green-light[data-v-315afb57]{background-color:#45b979;border-color:#45b979;color:#fff}.btn.btn-green-light[data-v-315afb57]:hover{background-color:#fff;color:#45b979}.btn.btn-disabled[data-v-315afb57]{background-color:#45b979;border-color:#45b979;color:#fff;cursor:default;opacity:.8}.btn.btn-disabled[data-v-315afb57]:hover{background-color:#fff;color:#45b979}.popup[data-v-315afb57]{background:#fff;bottom:0;box-shadow:0 -6px 14px -7px rgba(0,0,0,.7);height:200px;left:0;overflow:hidden;position:fixed;width:100%;z-index:1}.popup--open[data-v-315afb57]{height:87vh;overflow-y:auto}.bottom-notification-popup[data-v-315afb57]{padding:40px 0;position:relative}.popup-icon[data-v-315afb57]{background:none;border:none;color:#f6911e;cursor:pointer;font-size:40px;height:40px;line-height:0;position:absolute;right:15px;top:0;width:40px}',""]),t.exports=z},367:function(t,o,e){"use strict";e.r(o);e(15);var n={data:function(){return{isExpanded:!1,isDisplayed:!0}},mounted:function(){var t=this,element=document.querySelector("#bottom-notification");new IntersectionObserver((function(o){o.some((function(t){return t.intersectionRatio>0}))?t.isDisplayed=!1:t.isDisplayed=!0})).observe(element)}},r=(e(359),e(10)),component=Object(r.a)(n,(function(){var t=this,o=t._self._c;return t.isDisplayed?o("div",{class:[t.isExpanded?"popup--open":"popup--close","popup"]},[o("div",{staticClass:"container"},[o("div",{staticClass:"bottom-notification-popup"},[o("button",{staticClass:"popup-icon",on:{click:function(o){o.preventDefault(),t.isExpanded=!t.isExpanded}}},[t._v("\n        "+t._s(t.isExpanded?"-":"+")+"\n      ")]),t._v(" "),o("NotificationDetails")],1)])]):t._e()}),[],!1,null,"315afb57",null);o.default=component.exports;installComponents(component,{NotificationDetails:e(349).default})}}]);